Asthma Biologics Market By Asthma Type (Severe Eosinophilic Asthma, Allergic Asthma, Non-Eosinophilic Asthma, Late-Onset Asthma, Others), By Drug Class (Anti-IgE, Anti-IL5, Anti-IL4/IL13, Anti-TSLP, Others), By Age Group (Pediatric Patients, Adults, Geriatric Patients), By Route of Administration (Subcutaneous (SC), Intravenous (IV)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics, Online Pharmacies), and By End User (Hospitals, Specialty Clinics & Pulmonology Centers, Research & Academic Institutes, Homecare Settings), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Asthma Type

• Severe Eosinophilic Asthma
• Allergic Asthma
• Non-Eosinophilic Asthma
• Late-Onset Asthma
• Others

By Drug Class

• Anti-IgE
• Anti-IL5
• Anti-IL4/IL13
• Anti-TSLP
• Others

By Age Group

• Pediatric Patients
• Adults
• Geriatric Patients

By Route of Administration

• Subcutaneous (SC)
• Intravenous (IV)

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Specialty Clinics
• Online Pharmacies

By End User

• Hospitals
• Specialty Clinics & Pulmonology Centers
• Research & Academic Institutes
• Homecare Settings

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Amgen Inc.
• AstraZeneca
• Novartis International AG
• GlaxoSmithKline (GSK)
• Regeneron Pharmaceuticals
• Sanofi
• Bayer AG
• Teva Pharmaceutical Industries Ltd.
• Merck & Co., Inc.
• Eli Lilly and Company
• Boehringer Ingelheim GmbH
• Roche
• Johnson & Johnson
• Pfizer Inc.
• UCB Pharma